Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: COVID-19  May 28, 2020  3 years, 10 months, 3 weeks, 1 hour, 41 minutes ago

MUST READ!!! Brazilian Respiratory Expert Says That COVID-19 Should Be Treated As A Thrombotic Disease

MUST READ!!! Brazilian Respiratory Expert Says That COVID-19 Should Be Treated As A Thrombotic Disease
Source: COVID-19  May 28, 2020  3 years, 10 months, 3 weeks, 1 hour, 41 minutes ago
COVID-19: Medical researchers and respiratory experts from the University of São Paulo's Medical School say that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis and that the focus should be on treating COVID-19 as a thrombotic disease caused by a virus.



Their research findings and reports were published in the international medical publication called Journal of Thrombosis And  Haemostasis. https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14844

The first medical scientists to report the "thrombotic nature" of the disease caused by the novel coronavirus (SARS-CoV-2) was Dr Elnara Negri, a researcher and pulmonologist at Hospital das Clínicas, the hospital complex run by University Of San Paulo. the largest in Latin America and Hospital Sírio-Libanês, a leading private hospital also in São Paulo City.

Dr Negri told Thailand Medical News, "Around March 25, we were treating a patient whose breathing was rapidly deteriorating. When she was intubated, I observed that her lungs were easy to ventilate. They were not hardened and stiff, as you'd expect in someone with acute respiratory distress. Shortly thereafter, I noticed that the patient had an ischemic toe."

The toe condition has been referred to as COVID-toe and can affect all ten toes. It is caused by the obstruction of the small blood vessels that circulate blood in the feet. Dr Negri observed a similar phenomenon many years ago in patients who underwent open heart surgery with extracorporeal circulation.

She said. "In the old days, a device was used to pump oxygen into the blood, and clots would form inside the blood vessels. I had seen the condition before and knew how to treat it.”

Dr Negri prescribed heparin, one of the most widely used anti-coagulant drugs worldwide. In under 18 hours, the patient's oxygen saturation improved, and her angry red toe regained a healthy pink color. The same effect was achieved with other patients treated at the Sírio-Libanês hospital.

Dr Negri added,  "Since that day, we have treated approximately 80 COVID-19 patients, and so far, none of them has died. Four are currently in the ICU. The rest are in the ward or have been discharged.”

Many studies and clinical observations show that severe COVID-19 patients require 28 days of mechanical ventilation on average, whereas those treated with heparin typically improve after ten to 14 days of intensive care.

A medical study by Dr Negri and her colleagues describing their clinical experience with the first 27 patients who were treated with the protocol developed at Sírio-Libanês hospital is available on medRxiv as a preprint (not yet peer-reviewed) version. https://www.medrxiv.org/content/10.1101/2020.04.15.20067017v3

Just after the first successful administration of heparin, DR Negri shared the finding